quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:00:00·765d
PRRelease
Icosavax Inc. logo
Lyell Immunopharma Inc. logo
Sana Biotechnology Inc. logo

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)

ICVX· Icosavax Inc.LYEL· Lyell Immunopharma Inc.SANA· Sana Biotechnology Inc.
Health Care
Original source

Companies

  • ICVX
    Icosavax Inc.
    Health Care
  • LYEL
    Lyell Immunopharma Inc.
    Health Care
  • SANA
    Sana Biotechnology Inc.
    Health Care

Recent analyst ratings

  • Apr 10LYELUpdateNeedham$44.00
  • Mar 9LYELUpdateCitizens$34.00
  • Dec 9LYELUpdateH.C. Wainwright$45.00
  • Sep 24SANAUpdateWedbush$5.00
  • Jul 3SANAUpdateMorgan Stanley$12.00
  • Mar 18SANAUpdateCitizens JMP$5.00

Related

  • SEC9d
    SEC Form EFFECT filed by Lyell Immunopharma Inc.
  • SEC10d
    SEC Form 424B5 filed by Sana Biotechnology Inc.
  • SEC10d
    Sana Biotechnology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR10d
    Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
  • ANALYST13d
    Needham initiated coverage on Lyell Immunopharma with a new price target
  • INSIDER15d
    SEC Form 4 filed by Bishop Hans Edgar
  • PR16d
    Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
  • PR17d
    Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022